Global Fragment Based Drug Discovery Market Is Driven By Increasing Demand For Personalized Medicine

By Author: colin
Total Articles: 197
Comment this article

The Global Fragment Based Drug Discovery Market has experienced significant growth in recent years. Fragment based drug discovery is a biophysical screening technique used in drug discovery that relies on identifying fragments that bind to the target protein with high efficiency. These fragments act as starting points for drug design and development. The technique is advantageous over high-throughput screening as it helps identify lead compounds with improved affinity and selectivity. It also enhances success rates in drug discovery programs.
The Global Fragment Based Drug Discovery Market is estimated to be valued at US$ 0.795 Bn in 2024 and is expected to exhibit a CAGR of 15.% over the forecast period 2024-2031.
Key Takeaways
Key players operating in the global fragment based drug discovery are Astex Pharmaceuticals, Beactica AB, Charles River Laboratories International, Inc., Evotec AG, and Alveus Pharmaceuticals Pvt. Ltd.
The market is witnessing growing demand fueled by the rising prevalence of chronic diseases and increasing focus on developing personalized medicines. Pharmaceutical companies ...
... are widely adopting fragment-based screening to enhance drug discovery outcomes.
Various market players are also expanding their geographical presence to leverage growth opportunities in emerging markets. For instance, companies are collaborating with regional research institutes and setting up R&D centers in Asia Pacific and Latin America.
Market Drivers
One of the major factors driving the growth of the fragment based drug discovery market is the increasing demand for personalized medicine. Fragment based screening assists in developing drugs tailored to an individual's genetic profile. It enhances the chances of a drug candidate's clinical approval and commercial success. Additionally, the technique improves screening productivity and efficiency compared to conventional high throughput screening. This helps reduce drug development costs and time to market.
Impact Of Geopolitical Situation On Global Fragment Based Drug Discovery Market Growth
The current geopolitical tensions and instability across various regions are adversely impacting the Global Fragment Based Drug Discovery Market. The ongoing Russia-Ukraine war has disrupted supply chains and increased economic uncertainties. Several countries have imposed sanctions on Russia which is a major player in the market. This has hindered collaborations and exchange of resources between companies. Furthermore, the rising inflationary pressures due to disruptions are constraining the R&D budgets of pharma companies. They are forced to cut costs and focus only on critical projects. The political instability and conflicts in Middle East are also creating challenges for market players to expand operations and conduct clinical trials in these areas.
Going forward, companies will need to diversify their supplier base and closely monitor the geopolitical developments to mitigate risks. They should look for new strategic partners in politically stable regions. Establishing local manufacturing facilities can help insulate them from supply chain disruptions. Similarly, developing low-cost screening and analytics techniques can boost R&D productivity amid budget constraints. Collaborating with academic institutions and startups can expand capabilities at lower costs. Regional governments should incentivize pharma industry with tax rebates and subsidies to encourage sustained investments despite an uncertain global environment.
Regional Analysis Of Global Fragment Based Drug Discovery Market
North America currently dominates the Global Fragment Based Drug Discovery Market, accounting for over 40% value share. This is due to presence of leading pharma companies and research institutes in US and Canada. They are undertaking new drug discovery programs using FBDD techniques. Meanwhile, growing applications of structural biology and biophysics are propelling market growth in Europe. Countries like UK, Germany, and France have seen rising investments in industrial research.
Asia Pacific is identified as the fastest growing region with a CAGR of around 20% during the forecast years. This impressive growth can be attributed to increasing investments by governments as well as pharma companies to strengthen local R&D capabilities. Rapid economic development, prevalence of chronic diseases, and expanding biotech industry are driving market growth in emerging nations like China and India. Additionally, favorable regulations and low-cost skilled workforce are encouraging Western companies to establish offshore research centers in Asia Pacific.
Get more insights on this topic: https://www.bloglovin.com/@colin12/smart-drug-design-through-fragment-based

About Author:
Priya Pandey is a dynamic and passionate editor with over three years of expertise in content editing and proofreading. Holding a bachelor's degree in biotechnology, Priya has a knack for making the content engaging. Her diverse portfolio includes editing documents across different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc. Priya's meticulous attention to detail and commitment to excellence make her an invaluable asset in the world of content creation and refinement. (LinkedIn - https://www.linkedin.com/in/priya-pandey-8417a8173/)
What Are The Key Data Covered In This Global Fragment Based Drug Discovery Market Report?
:- Market CAGR throughout the predicted period
:- Comprehensive information on the aspects that will drive the Global Fragment Based Drug Discovery Market's growth between 2024 and 2031.
:- Accurate calculation of the size of the Global Fragment Based Drug Discovery Market and its contribution to the market, with emphasis on the parent market
:- Realistic forecasts of future trends and changes in consumer behaviour
:- Global Fragment Based Drug Discovery Market Industry Growth in North America, APAC, Europe, South America, the Middle East, and Africa
:- A complete examination of the market's competitive landscape, as well as extensive information on vendors
:- Detailed examination of the factors that will impede the expansion of Global Fragment Based Drug Discovery Market vendors
FAQ’s
Q.1 What are the main factors influencing the Global Fragment Based Drug Discovery Market?
Q.2 Which companies are the major sources in this industry?
Q.3 What are the market’s opportunities, risks, and general structure?
Q.4 Which of the top Global Fragment Based Drug Discovery Market companies compare in terms of sales, revenue, and prices?
Q.5 Which businesses serve as the Global Fragment Based Drug Discovery Market’s distributors, traders, and dealers?
Q.6 How are market types and applications and deals, revenue, and value explored?
Q.7 What does a business area’s assessment of agreements, income, and value implicate?
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it